Pfizer To Settle FCPA Bribery Probe For $60M
The potential settlement, reported Monday by The Wall Street Journal, comes amid a broader U.S. crackdown on pharmaceutical companies over potential violations of the anti-bribery Foreign Corrupt Practices Act. Earlier this year, Johnson & Johnson agreed to pay U.S. regulators $70 million to settle bribery and kickback allegations involving overseas business.
In a Nov. 10 regulatory...
To view the full article, register now.